Medication for the treatment of diseases of the urinary tract

Consumers survey results of 2019 in category

Gynecology, urology, nephrology / Medication for the treatment of diseases of the urinary tract

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	2	Урохолум (Vishpha \| Фармацевтична фабрика Vishpha)	36.79%	5

2.	1	Уролесан (Arterium Corporation)	37.26%	4.87

3.		Канефрон Н (Bionorica)	29.25%	3.85

4.	5	Нефрофіт (Aim)	10.85%	1.48

5.	6	Diurol (Валартін Фарма)	10.38%	1.39

6.	4	Цистон (Фірма ТК Комфорт)	8.96%	1.21

7.	12	Nephrocare (Delta Medical)	6.13%	0.81

–.	9	~~Фітолізин Плюс (Farmak)~~	~~5.66%~~	~~0.79~~

8.	13	Берёзы почки (Ternopharm)	5.19%	0.77

9.	18	Фітоліт (Pharmaceutical company “Zdorovya”)	5.66%	0.73

10.	8	Цисто-аурин (Esparma)	5.19%	0.70

11.	15	Уро-гран (Національна гомеопатична спілка)	5.66%	0.66

12.	11	Афлазин (Валартін Фарма)	4.72%	0.62

12.	10	Уро-Ваксом (Astellas Europe)	4.72%	0.62

14.	7	Еспа-фоцин (Esparma)	4.25%	0.55

15.	14	Блемарен (Esparma)	3.77%	0.53

16.		Уростон (Progress pharma)	3.77%	0.47

17.		Уронат Медивит (Naturprodukt Vega (Dr. Theiss Naturwaren GmbH))	3.30%	0.46

The competitor which has taken 1st place in this rating — is the best and the most successful Ukrainian medication of 2019 in the “Medication for the treatment of diseases of the urinary tract” category!

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2019, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.